(Jalleh and colleagues, review, Journal of Clinical Investigation , 2026.) Sudden vision loss (a condition called NAION) is the scary headline
Heres what one Bay Area based company is doing to slim down household pets with a new GLP-1 implant clinical weight loss study for cats called MEOW-1
Because glucagon receptor signalling is part of the design, research discussions also pay attention to hepatic markers, lipid markers, and other cardiometabolic endpoints in substudies
Etiology Autoimmune Autoantibodies directed against postsynaptic acetylcholine receptors or receptor-associated proteins Most common: acetylcholine receptor antibodies (AChR-Ab) Less common: muscle-specific tyrosine kinase antibodies (MuSK-Ab), lipoprotein receptor-related protein antibodies (LRP4-Ab), or no detectable antibodies Association with other autoimmune diseases, including: A minority of patients with myasthenia gravis have no detectable antibodies (i.e., seronegative MG)
We constructed the naltrexone/topiramate cohort to compare semaglutide to naltrexone/topiramate for recurrent AUD risk in patients with obesity
[8-10] The research supports Eriomin as a multi-faceted ingredient that works through several complementary pathways increasing GLP-1 production, supporting healthy blood sugar levels, and promoting beneficial gut bacteria
